NAP6 Perioperative Anaphylaxis The Royal College of Anaesthetists’ 6 th National Audit Project Starting on 5 th February 2016.

Slides:



Advertisements
Similar presentations
National Audit Project Four NAP4. What is NAP4? A national audit of major complications of airway management in the UK.
Advertisements

Research and Development Department A Quick Guide to Using EDGE v2 for Researchers Version 1.2 – 23 February
National Adult Clozapine Titration Chart
Slides produced by the MBR Project Team
Regional Fertility Centre Joan Couhig Administration & Quality Co-ordinator Saturday 27 September 2014 Joan Couhig Administration & Quality Co-ordinator.
Computerised reporting and terminology John Williams BSG Endoscopy Section Symposium 19 March 2002.
Anaesthetic Emergencies Acute Anaphylaxis Dr T E Allan Palmer FRCA FANZCA MD
Benefits Realisation A description of the approach at LTHT Marianne Taylor eMedicines Lead Pharmacist.
The College of Emergency Medicine Acute Allergic Reaction.
WHAT IS CQI? Contact the CQI Committee: (360)
The National Mastectomy and Breast Reconstruction Audit Key findings of the Third Annual Report Slides produced by the MBR Project Team. © The National.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
The early use of Antibiotics in at Risk CHildren with InfluEnza Chief Investigator: Dr Kay Wang Senior Trial.
Stephen Cole SICSAG September 2009 “making donation usual, not unusual”
Medical Audit.
STUDENT ASSISTANCE LIAISON ONLINE QUARTERLY REPORTING Guidance On Understanding and Completing the Quarterly Reporting Form.
25 January 2013 Dr Ian Arnott UK Inflammatory Bowel Disease (IBD) audit Audit of inpatients with ulcerative colitis 1st January 2013 – 31st December 2013.
1989 Microsoft released ‘Office’ suite Berlin Wall comes down George Bush snr. becomes President USSR pulls out of Afghanistan First NCEPOD Report.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
ADVERSE EFFECTS OF DRUGS Phase II May Adverse Drug Reaction An adverse reaction to a drug is a harmful or unintended response. ADRs are claimed.
Welcome to February’s ETAG Su Long, Chief Officer.
National Comparative Audit of Blood Transfusion National Blood Service National Comparative Audit of Overnight Red Blood Cell Transfusion Prepared by Tanya.
Type I Hypersensitivity (Allergy and Anaphylaxis.
National Audit of Dementia – care in general hospitals National Audit of Dementia Royal College of Psychiatrists Centre for Quality Improvement 4 th Floor.
The Airway Backpack – An Innovative Systems Approach to Managing a Critical Airway Dr Andrew McKechnie Dr Jay Dasan Kings College Hospital, London Background.
EAE Training EAE Reporting and Assessment Overview DAIDS Regional Training Event, Regulatory Compliance Center Kampala, Uganda, September 2009 DAIDS Regional.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
Cardiac Output Monitor Survey The impact of NICE guidance and CQUIN payments on Cardiac Output Monitors in the NHS: A trainee led national survey Claire.
CLINICAL AUDIT A quick guide. Why Audit? ‘Clinical audit is about improvement. If you are not changing or improving things as a result of audit then ask.
DRUG INTERACTIONS. –Adverse drug effects –Hypersensitivity –Anaphylactic reactions.
Mette Krag, MD, coordinating investigator
Tracheostomy Training Survey – Assessing the Need for Education Dr Andrew McKechnie Dr Tom Bishop, Dr Shona Love, Dr Jay Dasan Kings College Hospital,
© National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. All rights reserved. Not to be reproduced in whole or in part.
Date of presentation Name of presenter UK IBD audit 3rd round Primary care questionnaire.
Anaesthetic Specific Information. Within the specialty in our Trust… Consultants in – Anaesthesia – Intensive Care Medicine and Anaesthesia – Pain Medicine.
5 th National Audit Project of the Royal College of Anaesthetists and Association of Anaesthetists of Great Britain and Ireland NAP5.
Dr Alex Goodwin Consultant Anaesthetist, NCEPOD Clinical Co-ordinator and author of the NCEPOD sepsis report NCEPOD report for sepsis study
BTS/ICS Guidelines for the ventilatory management of acute hypercapnic respiratory failure in adults British Thoracic Society Intensive Care Society.
CATEGORY: IMMUNE DYSFUNCTION Anaphylaxis Tariq El-Shanawany, University Hospital of Wales, UK Anaphylaxis is a severe, life-threatening, generalised or.
Module 6 Monitoring Events Supposedly Attributable to Vaccination or Immunization (ESAVIs) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
 SNAP-1 Coming to your hospital: Tuesday 13 th and Wednesday 14 th May 2014.
Delivered by supported by. What is the National Epistaxis Audit? A UK-wide two-cycle prospective audit of in-hospital epistaxis management and outcomes.
This is the biggest, trainee led, prospective national paediatric audit to date Our hospital is taking part.
Søren Marker Jensen, MD, coordinating investigator
Access to Epinephrine for Self-Administration (EPI Rph)
STAR and RAFT STAR Group is the Severn Trainees Anaesthetic Research (STAR) Group, which is a trainee led initiative to encourage trainee involvement.
MAINTAINING THE INVESTIGATOR’S SITE FILE
NAP4 case review Tim Cook.
Critical Care Services Pharmacist Royal Manchester Children’s Hospital
A Single Centre Experience In Managing Anaphylaxis In The Emergency Department Iman Nasr1; Joanna Lukawska1,2; Runa Ali1; Ikram Nasr3; Jason Pott1; Tim.
NAP6 Perioperative Anaphylaxis
National Diabetes Audit – An Overview
Methotrexate in Psoriasis Shared Care Guidelines
National audit of paediatric IBD service provision
9. Introduction to signal detection
Overview and Key Findings Prof Nigel Harper Clinical Lead, NAP6
CLINICAL FEATURES Dr K-L Kong, MD MBBS FRCA, Consultant Anaesthetist Dr Surendra Karanam, BSc MBBS MRCP FRCP FRCPath, Consultant Immunologist.
Allergy Clinic Perceptions: The NAP6 Baseline survey Prof
Immediate Management Prof Nigel Harper Clinical Lead, NAP6
Obstetrics Nuala Lucas OAA
Antibiotics Shuaib Nasser Cambridge University Hospitals NHS Foundation Trust NAP6 Steering Committee member.
NAP6 Paediatric cases Mark Thomas Paediatric Anaesthetist Great Ormond Street Hospital, London Council member, Association of Paedaitrc Anaesthetists.
Principal recommendations
MAINTAINING THE INVESTIGATOR’S STUDY FILE
NAP 6 Tools Tomaz Garcez Consultant Immunologist
NAP6 – the independent/private sector m Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.
The Patient Experience Mr John Hitchman RCoA Lay Representative
5 phases Baseline survey of anaesthetists perspectives/experiences
EAGLE STUDY SET-UP.
Presentation transcript:

NAP6 Perioperative Anaphylaxis The Royal College of Anaesthetists’ 6 th National Audit Project Starting on 5 th February 2016

Examine infrequent adverse events/outcomes related to anaesthetic practice Produce recommendation relating to their prevention, identification and management Long-term aim = improve safety & patient outcomes Criteria: 1.Important to patients 2.Important to anaesthetic community 3.Current uncertainty 4.Rare event What are the National Audit Projects (NAPs)?

Changes from the last NAP project Main principles the same but.. – Move to on-line baseline survey (not paper) – Return to simpler format of NAP3 and NAP4 – Ireland not taking part – Some Independent Sector hospitals participating

What is NAP6? A 1 year project in all UK NHS hospitals A 9 month project in some Independent Sector hospitals Recording all aspects of severe perioperative anaphylaxis on a case-by-case basis Adult and paediatric Auditing management and investigation against national guidelines Collaborative – with allergists and clinical immunologists

What is Anaphylaxis? A severe, life-threatening, generalized or systemic hypersensitivity reaction Usually allergic (Type 1, IgE-mediated) but sometimes non-allergic Massive release of mediators from mast cells and basophils Spectrum of clinical features, but only Grade 3 or greater is actually life-threatening

What is the NAP6 definition of perioperative anaphylaxis? Anaphylaxis which occurs: – in a patient undergoing a procedure requiring general or regional anaesthesia or sedation or managed anaesthesia care (anaesthetist monitoring only) AND – under the care of an anaesthetist AND – between the period of first administration of a drug (including pre-med) and the post-procedure transfer to the ward, HDU or ICU

Where? All hospital locations For practical reasons we include patients from HDU/ICU/ED only if: – a general anaesthetic is administered – by an anaesthetist – for an interventional (not resuscitation) procedure

Which cases should not be reported to NAP6? GRADEFEATURESREPORT ? 1Rash, erythema and/ or swellingNO 2Unexpected hypotension – not severe e.g. not requiring treatment and/or Bronchospasm – not severe e.g. not requiring treatment +/- Grade 1 features NO

Which cases should be reported to NAP6? GRADE FEATURES: suspected anaphylaxis and: REPORT ? 3Unexpected severe hypotension and/or Severe bronchospasm and/or Swelling with actual or potential airway compromise +/- Grade 1 features YES 4Cardiac arrest – i.e. fulfilling the indications for CPR YES 5FatalYES

Should I report this case to NAP6? yes Do I suspect anaphylaxis? yes Is it grade 3, 4 or 5? yes Is it ‘perioperative’? Do NOT report Do NOT report Report to NAP6 No

1.Baseline Survey for NHS Hospitals only (only the Brief Organisational Survey will apply to independent hospitals) 2.Main data collection period – Core Project 3.Activity (Allergen) Survey The 3 parts of NAP6

Part 1: Brief Organisational Survey o A survey of anaphylaxis preparedness and reporting practices in hospital organisations o Completed by the Local Coordinators on-line NAP6 in the independent sector

Part 2: Main data collection period – Core Project o 9 month period from February 2016 o Web-based, anonymised o Cases reported by the most senior anaesthetist involved, to avoid multiple-reporting o via hospital NAP6 Local Coordinator (LC) liaising with all anaesthetists involved in the case A – The anaphylactic event B – Information received from the allergy clinic following investigation NAP6 in the independent sector

Part 3: Activity (Allergen) Survey o Spring 2016 o To quantify exposure to a range of potential allergens during anaesthesia/sedation o All anaesthetists, including trainees o Paper questionnaire – completed for every patient o 2 day period (randomised to individual hospitals) o LCs collect completed questionnaires & return to the RCoA NAP6 in the independent sector

FebMar Apr MayJuneJulyAugSeptOct Feb 2016 Organisational Survey April 2016 Activity/Allergen Survey Start - Main Data Collection – Core Project FINISH* * Allergy clinic information collected for further 6 months NAP6 Timeline

Contact your Local Coordinator Obtain as much information as possible concerning the anaphylactic event LC will the RCoA NAP6 team and obtain a case- specific ID and password LC +/- index anaesthetist enter anonymised data via NAP6 website o Please select INDEPENDENT SECTOR when requested on the webtool o Initial data; as soon as possible after the event o Results of allergy investigations; immediately after receiving letter(s) from the allergy clinic How do I report a case to NAP6?

As in previous NAPs we have appointed a Moderator. The Moderator will be contactable to discuss cases where there is uncertainty as to whether the case meets inclusion criteria. The Moderator is otherwise not involved with the project and so all discussions are private. NAP6 Moderator

Local Coordinator: Contact Details *Add name* NAP6 NAP6 NAP Website: *Add Address*